Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PBM-LEF Study: The Impact of PBM on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients: A Feasibility Study

NCT06708754 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT06708754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06708754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PBM-LEF Study: The Impact of PBM on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients: A Feasibility Study
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Recruiting
Start date
February 13, 2025
Completion date
February 13, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, radiation fibrosis, radiation lymphedema